A detailed history of Boxer Capital, LLC transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 4,475,000 shares of PSTX stock, worth $13.5 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
4,475,000
Holding current value
$13.5 Million
% of portfolio
0.74%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.76 - $4.13 $12.4 Million - $18.5 Million
4,475,000 New
4,475,000 $14.3 Million
Q3 2021

Nov 15, 2021

SELL
$7.09 - $10.71 $8.87 Million - $13.4 Million
-1,251,055 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$8.09 - $16.25 $10.1 Million - $20.3 Million
1,251,055 New
1,251,055 $11.1 Million

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $259M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.